Edward M. Kaye M.D., Director at Stoke Therapeutics, Inc. (STOK), sold 84,922 shares at $25.09 ($2.1M) on 2025-10-03, disclosed to the SEC on 2025-10-07.
Scheduled sale ($2.1M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.09 | 42,461 | $1.1M | 50.0% |
| 2 | $25.09 | 42,461 | $1.1M | 50.0% |
| Total | $25.09 avg | 84,922 | $2.1M | 100% |
| Filing → |
| STOK | SELL | 2025-12-10 | $702K | — | Filing → |
| STOK | SELL | 2025-12-05 | $879K | — | Filing → |
| STOK | SELL | 2025-12-03 | $65K | — | Filing → |